eli lilly retatrutide clinical trials Retatrutide, Lilly’s Next-Gen Obesity Drug, Beats Out Zepbound in Late-Stage Trial Retatrutide Shows 28% Weight Loss
Pay in 4 interest-free payments of $5.39 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1

























